Patents by Inventor Ingrid G. WINKLER

Ingrid G. WINKLER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR THE MOBILIZATION AND USE OF T-CELLS WITH ENHANCED RECONSTITUTION POTENTIAL AND LIFE-SPAN
    Publication number: 20180228871
    Abstract: The disclosure provides a new source of peripheral blood naive/memory stem cells (i.e. (TN)/TSCM/TCM) T-cells with enhanced reconstitution potential and/or longer life spans. It discloses that this particular subset of T-cells can be mobilized by administration of at least one mobilizer in combination with at least one E-Seiectin inhibitor.
    Type: Application
    Filed: August 2, 2016
    Publication date: August 16, 2018
    Applicant: GlycoMimetics, Inc.
    Inventors: Rachel K. KING, John L. MAGNANI, Ingrid G. WINKLER
  • METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING MUCOSITIS
    Publication number: 20170296566
    Abstract: Methods for treating and/or preventing mucositis comprising administering to a subject in need thereof an effective amount of at least one compound chosen from E-selectin antagonists, pharmaceutically acceptable salts of E-selectin antagonists, prodrugs of E-selectin antagonists, and pharmaceutically acceptable salts of prodrugs of E-selectin antagonists, and compositions comprising at least one of such compound.
    Type: Application
    Filed: September 29, 2014
    Publication date: October 19, 2017
    Applicant: GLYCOMIMETICS, INC.
    Inventors: John L. MAGNANI, John M. PETERSON, Ingrid G. WINKLER
  • METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING MUCOSITIS
    Publication number: 20160243145
    Abstract: Methods for treating and/or preventing mucositis comprising administering to a subject in need thereof an effective amount of at least one compound chosen from E-selectin antagonists, pharmaceutically acceptable salts of E-selectin antagonists, prodrugs of E-selectin antagonists, and pharmaceutically acceptable salts of prodrugs of E-selectin antagonists, and compositions comprising at least one of such compound.
    Type: Application
    Filed: September 29, 2014
    Publication date: August 25, 2016
    Applicant: GLYCOMIMETICS, INC.
    Inventors: John L. MAGNANI, John M. PETERSON, Ingrid G. WINKLER